DVT Prophylaxis Post-Cholecystectomy with Elevated LFTs

Introduction to DVT Prophylaxis

The American College of Physicians recommends fondaparinux 2.5 mg subcutaneously once daily as a preferred pharmacologic alternative for DVT prophylaxis in patients with elevated LFTs post-cholecystectomy who cannot receive enoxaparin, with mechanical prophylaxis as an adjunct or standalone option if pharmacologic prophylaxis is contraindicated 1, 2

Patients in the 38-year-old age group represent a lower risk for DVT compared to patients over 60 years, according to the American Geriatrics Society 1, 3

The American College of Chest Physicians recommends dalteparin 5,000 units subcutaneously once daily as an alternative LMWH option for DVT prophylaxis in patients with elevated LFTs post-cholecystectomy 1, 2, 4
Dalteparin may be preferred over enoxaparin in patients with renal impairment (CrCl 30-50 mL/min) as it may be more safely cleared, though monitoring of anti-Xa levels is recommended, as suggested by the National Kidney Foundation 5
Unfractionated heparin 5,000 units subcutaneously every 8-12 hours is an established option for general medical and surgical patients, according to the American College of Physicians 1, 2, 4

The American College of Surgeons recommends graduated compression stockings and/or intermittent pneumatic compression when patients are at high risk for bleeding 1, 3

Prophylaxis should be continued for 7-10 days or until the patient is fully ambulatory, as recommended by the American College of Physicians 1, 4

Elevated LFTs may indicate underlying hepatic dysfunction, which increases bleeding risk with anticoagulation, according to the American Association for the Study of Liver Diseases 4, 6
Absolute contraindications to pharmacologic prophylaxis include active major bleeding, recent CNS bleed, severe thrombocytopenia, or underlying hemorrhagic coagulopathy, as stated by the American College of Cardiology 2

Assess renal function first: If CrCl <30 mL/min, fondaparinux is contraindicated; use dalteparin with anti-Xa monitoring or UFH, as recommended by the National Kidney Foundation 6, 5
Evaluate severity of LFT elevation and coagulation status: If coagulopathic or platelets <50,000, use mechanical prophylaxis only, according to the American College of Chest Physicians 6, 2